Find out how, as a responsible challenger, we’re making a meaningful contribution to this important public health strategy through consumer-centric science & innovation.
Nicotine is a simple chemical with a complicated history. Learn more about way it affects the body, its relationship with smoking and smoking-related disease, and more.
Exciting technological advances have enabled the decoupling of nicotine from tobacco combustion to create potentially harm reduced cigarette alternatives.
Transparency and collaboration are key to building belief in tobacco harm reduction and next generation products. Find out more about our science and innovation advocacy.
We believe it’s crucial to communicate our science to a wide range of audiences. Read press releases, blogs, and brochures, watch videos, and download infographics.
Learn more about our roots, our beliefs, and the talented teams helping Imperial Brands transform to offer our consumers potentially harm reduced cigarette alternatives.
Research Update: Tobacco-free oral nicotine pouches
Imperial Brands has conducted a comprehensive scientific assessment of its tobacco-free nicotine pouch products in comparison to combustible cigarettes. A summary of the evidence is presented here, demonstrating their significant tobacco harm reduction potential.
Tobacco Harm Reduction (THR) represents one of the most promising global public health policies: to encourage adult smokers who would otherwise continue to smoke to transition to less harmful products that deliver nicotine, but with fewer and substantially lower levels of toxicants associated with burning tobacco.
Recent advances in technology have created a completely new range of innovative alternative nicotine products that have the potential to be significantly less harmful than combustible cigarettes for adult smokers.
Among these Next Generation Products (NGPs) are tobacco-free oral nicotine pouches. Typically, these small pouches contain high purity pharmaceutical grade nicotine sprayed onto dry powder or a plant fibre-based substrate, and other high-quality ingredients including flavourings, humectants to retain moisture, and additives to ensure product stability.
Imperial Brands believes its tobacco-free oral nicotine pouches have an important contribution to make to THR and is committed to supporting the category. As part of our rigorous Scientific Assessment Framework for all our NGPs, IMB Science has produced an a summary of the key scientific findings that substantiate the THR potential of our products through the following nine lines of scientific evidence.
Line of Evidence I: Our nicotine pouch products contain substantially lower levels of select toxicants of notable public health interest compared to combustible cigarette smoke.
Line of Evidence II: The reduced levels of toxicants in our nicotine pouch products translates directly into substantially reduced in vitro biological responses (mutagenicity, genotoxicity, and cytotoxicity) compared to combustible cigarette smoke condensate: on average >99% reduction in cytotoxicity with no mutagenic or genotoxic responses under the conditions of test.
Line of Evidence III: In laboratory models, our nicotine pouch products do not elicit skin sensitisation properties.
Line of Evidence IV: Our nicotine pouch products deliver nicotine to the blood of adult smokers via the oral mucosa (not swallowed), which on average have a lower and slower nicotine delivery compared to combustible cigarettes. As such, our nicotine pouches likely have a lower dependency potential compared to combustible cigarettes, but this should not be interpreted as evidence that these products are not addictive.
Line of Evidence V: Our nicotine pouch products offer a satisfying alternative to combustible cigarettes and reduce adult smokers’ desire to smoke.
Line of Evidence VI: Our nicotine pouches have a favourable short-term safety and tolerability profile during the observation period with no serious adverse events related to the product observed.
Line of Evidence VII: Adult smokers and non-smokers properly understand that our nicotine pouches contain nicotine and are not risk-free but are likely to be less harmful than combustible cigarettes.
Line of Evidence VIII: Our nicotine pouch products appeal overwhelmingly to adult smokers with very low interest amongst never smokers and former smokers. There is little evidence they would serve as a gateway to regular nicotine use amongst nicotine naïve populations.
Line of Evidence IX: The main reason for adult smokers’ interest and intent to purchase our products is for harm reduction and to reduce the health risks associated with combustible cigarette smoking.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
